Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial
Released 14 Dec 25
Latest announcements
Announcement summary
Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial
Ask a question
Your question will be sent privately to Cynata Therapeutics. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Cynata Therapeutics a question about this announcement.